Studies evaluating serum irisin levels in individuals with obesity have mostly shown a relationship between high irisin levels and a decreased risk of associated comorbidities, such as type 2 diabetes mellitus and other cardiometabolic disorders. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.